Overexpression of p53 protein in tumours induces an immune response, and among cancer patients, those with colorectal cancer have the highest prevalence of p53-Ab ranging from 13 to 32% (Angelopoulou et al, 1997). This evidence concerns the gene TP53 and cancer.